{"nct_id":"NCT00524303","title":"Lapatinib +/- Trastuzumab In Addition To Standard Neoadjuvant Breast Cancer Therapy.","status":"COMPLETED","status_verified_date":"2016-03","start_date":"2007-08","start_date_type":null,"primary_completion_date":"2010-10","primary_completion_date_type":"ACTUAL","completion_date":"2015-08","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["GSK"]}